NAPROXEN SODIUM - naproxen sodium tablet, film coated 
WALMART INC.

----------

Naproxen Sodium Tablets, USP 220 mg

Drug Facts

Active ingredient (in each caplet)

Naproxen sodium USP 220 mg (naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Purposes

Pain reliever/fever reducer

Uses

Warnings

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:



If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning:
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:


Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

Ask a doctor before use if

Ask a doctor or pharmacist before use if you are

When using this product

Stop use and ask a doctor if

If pregnant or breast-feeding,

ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions


 Adults and children
 12 years and older
  • take 1 caplet every 8 to 12 hours while symptoms last
  • for the first dose you may take 2 caplets within the first hour
  • do not exceed 2 caplets in any 8 to 12 hour period
  • do not exceed 3 caplets in a 24 hour period
 Children under 12 years
  • ask a doctor

Other information

Inactive ingredients

colloidal silicon dioxide, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide

Questions or comments?

1-888-287-1915

DISTRIBUTED BY:
Walmart Inc.,
Bentonville, AR 72716

PRODUCT OF INDIA

**This product is not manufactured or distributed by
Bayer HealthCare LLC, distributor of Aleve® Caplets.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (50 Tablets Bottle)

NDC 79903-231-50

equate
All Day Pain Relief

Naproxen Sodium
Tablets
USP, 220 mg
(NSAID)

Pain Reliever/
Fever Reducer
Strength to Last 12 Hours

12
HOURS

220                50
mg             CAPLETS
                  Capsule-Shaped Tablets



PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablet Bottle)


PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (50 Tablets Carton Label)

NDC 79903-231-50
equate

Compare
to Aleve®
caplets
active
ingredient**

All Day
Pain Relief

Naproxen Sodium
Tablets USP,
220 mg
(NSAID)


Pain Reliever/
Fever Reducer
Strength to                    
12
Last 12 Hours            HOURS

                                
                                     220            50
                                     mg        CAPLETS
                                    EACH
Actual Size                 Capsule-Shaped Tablets


PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablets Carton Label)

NAPROXEN SODIUM 
naproxen sodium tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:79903-231
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)  
POVIDONE K30 (UNII: U725QWY32X)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorBLUE (light blue) Scoreno score
ShapeOVALSize12mm
FlavorImprint Code K;45
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:79903-231-501 in 1 CARTON02/14/2024
150 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20549702/14/2024
Labeler - WALMART INC. (051957769)
Registrant - Aurohealth LLC (078728447)
Establishment
NameAddressID/FEIBusiness Operations
Aurobindo Pharma Limited650381903ANALYSIS(79903-231) , MANUFACTURE(79903-231)

Revised: 4/2024
Document Id: 868992f2-9eae-4d25-b135-e6a303bc0c4d
Set id: 09b52dd4-0434-237c-e063-6294a90ab9b5
Version: 2
Effective Time: 20240403
 
WALMART INC.